Vaccine and antibody production in plants : developments and computational tools by Dubey, Kashyap Kumar et al.
For Peer Review
1 
 
Vaccine and antibody production in plants: developments and computational tools 1 
 2 
Kashyap Kumar Dubey1,2*, Garry A Luke3, Caroline Knox4, Punit Kumar2, Brett I. Pletschke4, 3 
Puneet Kumar Singh5, Pratyoosh Shukla5* 4 
1Department of Biotechnology, Central University of Haryana, Jant-Pali Mahendergarh, 5 
Haryana, India 6 
2Microbial Process Development Laboratory, University Institute of Engineering and 7 
Technology, Maharshi Dayanand University, Rohtak, Haryana, India 8 
3Centre for Biomolecular Sciences, School of Biology, University of St Andrews, North Haugh, 9 
St Andrews, Fife, KY16 9ST, Scotland, UK. 10 
4Department of Biochemistry and Microbiology, Rhodes University, Grahamstown, South Africa 11 
5Enzyme Technology and Protein Bioinformatics Laboratory, Department of Microbiology, 12 
Maharshi Dayanand University, Rohtak, Haryana, India 13 
*Corresponding author 14 
E-mail: pratyoosh.shukla@gmail.com 15 
Phone: +91-1262-393398;  Fax: +91-1262-274133 16 
Dr. Kashyap Kumar Dubey 17 
Dr. Kashyap Kumar Dubey is presently working as Associate Professor and Head of Department 18 
of Biotechnology at Central University of Haryana, India. His research interests are in the field 19 
of bioprocess engineering and plant based metabolites. 20 
Dr.  Garry A Luke  21 
Dr. Garry A. Luke is Research Fellow at School of Biology at University of St Andrews, UK. He 22 
research interests are in the field of virology and molecular biology. 23 
 24 
Page 1 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
2 
 
 Dr. Caroline Knox  25 
Dr. Caroline Knox is Associate Professor at Department of Biochemistry, Microbiology and 26 
Biotechnology, Rhodes University South Africa. Her research interests are in the field of 27 
virology. 28 
Dr. Punit Kumar: 29 
Dr. Punit Kumar is Ph.D. in Biotechnology from M.D. University, Rohtak, India. His research 30 
interests are in the field of microbiology and plant based metabolites. 31 
Prof. Brett I. Pletschke  32 
Dr. Brett Pletschke is Professor at Department of Biochemistry, Microbiology and 33 
Biotechnology, Rhodes University South Africa. His research interests are in the field of 34 
Enzymes, Enzyme Inhibitors and the Bio economy. 35 
Puneet Kumar Singh 36 
Dr. Puneet Kumar Singh is PhD from Microbiology from M.D. University, Rohtak, India. His 37 
research interests are in the field of Bioinformatics and systems biology. 38 
Dr. Pratyoosh Shukla 39 
Dr. Pratyoosh Shukla is Professor and Head at Department of Microbiology at M.D. University, 40 
Rohtak, India. His research interests are in th  field of enzyme technology and protein 41 
bioinformatics. 42 
 43 
 44 
 45 
 46 
 47 
 48 
Page 2 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
3 
 
Abstract 49 
Plants as bioreactors have been widely used to express efficient vaccine antigens against viral, 50 
bacterial and protozoan infections. To date, many different plant-based expression systems have 51 
been analyzed, with a growing preference towards transient expression systems. Antibody 52 
expression in diverse plant species for therapeutic applications is well known and this review 53 
provides an overview of  various aspects of plant based biopharmaceutical production. Here, we 54 
highlight conventional and gene expression technologies in plants along with some illustrative 55 
examples. In addition, the portfolio of products that are being produced and how they relate to 56 
the success of this field are discussed. Stable and transient gene expression in plants, 57 
agrofiltration, and virus infection vectors are also reviewed. Further, the present report draws 58 
attention to antibody epitope prediction using computational tools, one of the crucial steps of 59 
vaccine design. Finally, regulatory issues, biosafety and public perception of this technology are 60 
also discussed. 61 
 62 
Keywords: Epitope prediction; Computational tools; Genetic engineering; Plantibody; Edible 63 
vaccine. 64 
 65 
1. Introduction 66 
Currently, many types of transgenic cells are the used as source material in vaccine production. 67 
When antigens are expressed in wild or engineered systems, processing to remove toxins and 68 
host proteins, contributes to increase production costs [1]. Moreover, these systems are also 69 
sensitive to contamination by other microorganisms that often escape detection in pure vaccines. 70 
In response to the challenges faced by current pharmaceutical production practices, plant 71 
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molecular farming (PMF) has emerged as a viable technology for the production of recombinant 72 
proteins like enzymes, monoclonal antibodies (mAbs) and antigens for human and animal 73 
vaccines [2,3,4]. Plant expression systems have several intrinsic advantages vis-á-vis bacteria, 74 
yeast, insect or mammalian systems in terms of speed, costs, scalability and safety [5, 6]. In 75 
addition, plants have the capacity to perform post-translational changes which are important in 76 
protein folding, trafficking, stability and biological activity [7,8]. Plant derived antibodies 77 
(PDAbs) have been developed for the protection against different pathogens, including viruses, 78 
bacteria and fungi [9, 10]. Investigators have also analyzed plant-based expression systems with 79 
a growing preference towards transient expression systems [1,11]. There are several notable 80 
reports on stable transformation of plant nuclear and plastid genomes [12, 13, 14]. Furthermore, 81 
alternative approaches such as systems biology and gene editing have been reported for 82 
developing therapeutic products in other organisms. These studies pave the way to adopt these 83 
concepts to plant derived antibody production [15, 16].  84 
In this article we review conventional and state of the art plant-based gene expression 85 
technologies along with some illustrative examples (Figure 1). 86 
 87 
2. The expression of antigens in plants 88 
 89 
2.1 Stable and transient expression of antigens 90 
During stable transformation, the foreign gene is integrated into the genome of the cell using 91 
Agrobacterium or biolistic approaches (microprojection, bombardment and protoplast 92 
transformation). However, this type of transformation has some shortcomings; Agrobacterium 93 
has target limitations and expression of desired protein with respect to total soluble plant protein 94 
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is low (0.01% to 0.30%) [17]. Alternatively, in transient systems, the foreign gene is expressed 95 
without being integrated into the genome [17]. Traditionally, the process of generation of stable 96 
transgenic lines is time consuming and cumbersome whereas, transient expression systems are 97 
rapid and simple.  98 
 99 
 100 
For rapid development of vaccines, attempts were made to explore transient gene expression. 101 
Examples of the transformation of antigen genes into plant genomes are outlined in Tables 1-3.  102 
 103 
Insert Table 1, Table 2, Table 3 104 
 105 
Initial studies described the production of a surface protein (spa A) from Streptococcus mutans 106 
(0.02 % of total leaf protein) in tobacco plant [18]. Early attempts for vaccine production used 107 
transgenic plants for expression of LT-B (heat labile) protein (0.05% of total soluble proteins) of 108 
E. coli in tobacco plant [19] (Rosales-Mendoza et al., 2011). In case of diarrhea, the enterotoxin 109 
B subunit (LTB) from E. coli and cholero toxin (CT), were expressed in chloroplast genome of 110 
tobacco, ,maize and rice [20,21,22].  111 
2.2 Plant virus fusion proteins 112 
Plant viral vectors represent a promising approach for the expression of antigenic epitopes with 113 
self-assembling viral peptides since they can mount simple and rapid infections, allowing 114 
production of large amounts of recombinant protein in susceptible host [23]. The widely-used 115 
technique for transient transformation uses recombinant plant viruses as protein-expression 116 
vectors such as potato virus X (PVX), cowpea mosaic virus, tobacco mosaic virus (TMV), and 117 
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cucumber mosaic virus (CMV) etc. A generalized diagram of recombinant PDAbs production 118 
versus selective breeding is presented in Figure 2. This explains how these specified methods can 119 
be pivotal towards effective PDAbs production. The CT of V. cholerae has two components, CT-120 
A and CT-B, where CT-B is accounted for mucosal and serum immunity [24]. The genes for ctB 121 
were cloned in plant expression vectors and transformed into tobacco plants [25].  122 
It is also feasible to express foreign proteins with viral coat protein (CP). Advantages of this 123 
“overcoat” approach are the relative ease with modified viral particles can be purified from 124 
infected tissues and the presentation of  numerous copies of an antigenic peptide on the surface 125 
of a macromolecule carrier can drastically augment its immunogenicity [26]. The epitopes from 126 
various pathogens have been expressed in plants using various coat proteins from plant viruses as 127 
carriers (Table 3). The D2 epitope of the fibronectin binding protein B of Staphylococcus aureus 128 
was expressed with the coat protein of Cowpea Mosaic Virus (CPMV). Treatment induced both 129 
serum and mucosal antibodies against the D2 peptide. Similarly, a capsid protein from Norwalk 130 
virus was expressed in tomato [27]. In CPMV, an icosahedral viral particle with several useful 131 
properties, a coat protein gene was used to encode fusion recombinant antigens [28]. One more 132 
study reported the expression of recombinant CPMV coat protein fused with the VPI epitope of 133 
human rhinovirus in cowpea leaves [29]. One example reported the expression of Norwalk virus 134 
capsid protein (NVCP) with a 35S CaMV promoter or a potato specific patatin promoter in 135 
conjunction with A. tumefaciens, The construct was transformed into the tobacco and 136 
microtubers of potato to produce NVCP protein [30]. Furthermore, expression of the surface 137 
antigen hepatitis B virus (HbaAg) was reported in tobacco [31], in leaves of potato [32], in 138 
tomato [33]. In a recent study, investigators demonstrated that transformation of the Nicotiana 139 
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benthamiana with RhoA peptide resulted in successful protein expression and reduced growth of 140 
respiratory synctial virus [34].  141 
Nevertheless, CP fusions are not tolerated as they can obstruct particle assembly and spread [35]. 142 
This has been largely overcome by introducing the foot-and-mouth disease virus (FMDV) 2A 143 
peptide between the heterologous sequence and the CP ORF (Figure 3). The expressed proteins 144 
were efficiently assembled into particles and encapsidated the viral RNA without any significant 145 
effect on the virus viability [35]. Having established the utility of the approach, several antigen 146 
candidates have reported rotavirus inner capsid protein (VP6) [36], swine fever virus (SFV) E2 147 
glycoprotein [37], tuberculosis ESAT-6 protein [38], and the hepatitis C virus (HCV) envelope 148 
protein R9 [39]. PVX virions carrying the CSFV glycoprotein epitope produced an 149 
immunoprotective response in rabbits [37] and the R9 epitope on the surface of PVX particles 150 
was highly immunogenic in mice [39]. Other pox viruses with a variety of hosts have also been 151 
utilized to express a foreign gene as a fusion protein with CP, separated by the FMDV 2A 152 
peptide: pepino mosaic virus (PepMV) infecting N. benthamiana plants [40] and Plantago 153 
asiatica mosaic virus (PIAMV) infecting N. bethamiana and Arabidopsis thaliana [41]. The 154 
bipartite CPMV has been extensively used as a virus vector system based on transgenic for the 155 
expression of proteins in plants. The use of 2A instead of viral cleavage motifs diminished the 156 
number of virus-derived amino acids linked to the expressed foreign protein, and as in PVX 157 
“overcoat” vectors, some of the protein is present in virus particles. This approach has 158 
subsequently been used to express hepatitis B virus (HBV) nucleocapsid protein (HBcAg) [42] 159 
and small immune proteins (SIPs) specific for transmissible gastroenteritis virus [43]. In 160 
soybean-infecting bean pod mottle virus (BPMV) vectors, non-identical FMDV-2A peptide 161 
sequences were used both to assist simultaneous co-expression of two dissimilar proteins, and to 162 
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reduce instability of the introduced genetic elements [44]. Recently expression of synthetically 163 
stabilized virus-like particle (sVLP) for vaccine with D antigenicity of poliovirus was reported in  164 
N. benthamiana [45].  165 
2.3 Edible vaccines 166 
In developing countries vaccine costs can be  a limiting factor in healthcare. A published report 167 
in Decade of Vaccines (DoV), indicated that the total cost of vaccination had increased 168 
significantly from $1.37 in 2001 (to vaccinate against six diseases) to $38 in 2011 (for 11 169 
diseases) [46]. In another study it was reported that bacterial and viral antigens were expressed in 170 
edible plants and ingestion of these plants containing vaccine proteins has shown antigenicity. 171 
Thus, alternative economical vaccination methods such as edible vaccines have recently gained 172 
attention [47-49]. These vaccines, defined as mucosal-targeted vaccines, (which originate) bring 173 
about a prompt systematic and mucosal immune response. The functional site of mucosa-174 
associated lymphoid tissues (MALT) is associated with the gut, lungs and bronchial system. The 175 
secretory antibody IgA functions to prevent virus entry and (also) clump antigens which are 176 
removed from the body in the mucus or faeces. It is pertinent to mention that oral vaccine 177 
supposedly sustain activity in the intestine at acidic pH [50].  178 
The Tobacco (N. tabacum) plant has shown to be an efficient system for expressing different 179 
forms of antibodies, secretory IgG and IgA, single-chain variable fragments (scFv), [51], Fab 180 
fragments, and bispecific antibodies. For example, monoclonal antibodies of a single chain 181 
variable fragment (scFV) against the West Nile virus have been made as a fusion protein in 182 
glycol-engineered N. benthamiana [52, 53]. Inoculation with full-length or deleted versions of 183 
RNA-2 comprising the heavy and light chains of a murine blood group-typing antibody fused 184 
with the C-terminus of the small coat protein domain via F2A resulted in the expression of  185 
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assembled full-size IgG in N. bethamiana [54]. This approach has also been used to express 186 
derivatives of scFvs specific for transmissible gastroenteritis virus (TGEV) in cowpea plants and 187 
the crude plant extracts supplied ad libitum to neonatal pigs to provide in vivo protection against 188 
challenge with this enteric pathogen [43]. Further, transient expression of antigenic epitopes of 189 
the rabies virus (RV) was also reported in tobacco, spinach and Nicotiana benthamiana, and 190 
successful immunization of mice was observed by feeding transgenic spinach [14]. Another 191 
interesting study reported the fusion of complementary DNAs (cDNA) of cholera toxin (CT) 192 
subunit B and A2 with the enterotoxin gene of rotavirus and enterotoxigenic fimbrial antigen 193 
gene of E. coli. This was transferred into potato resulting in the expression of fusion antigens in 194 
transformed tissues. 195 
These antigens were assembled into cholera holotoxin-like structures and exhibited affinity for 196 
enterocyte. The oral immunization into mice caused production of antibodies for pathogen 197 
antigens. Thus it may be suggested that edible vaccine can provide simultaneous protection 198 
against viral and bacterial pathogen [55]. 199 
There are reports about corn based vaccines and ginger derived nanoparticles, including the use 200 
of plant glycans [56-58]. In one more study, transgenic tobacco leaves and potato tubers were 201 
established which were capable of producing GAD (glutamic acid decarboxylase), a diabetes-202 
associated antigen for treatment of Type II diabetes. The expression was detected at a level of 203 
0.33 to 1.0 mg/g of fresh weight. Feeding 3 g transgenic plant tissue daily from 5 weeks to 8 204 
months showed diabetes only in 2 out of 12 mice [59].  205 
 206 
 207 
 208 
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3. Alternative approaches for plant-derived antibodies 209 
3.1 Chloroplast transformation for vaccine production 210 
Chloroplast transformation has been widely studied for the expression of a variety of compounds 211 
[60] and the cheap production of vaccines. Chloroplast genetic engineering offers several 212 
advantages over nuclear transformation: (as)  increased biosafety related to release of integrated 213 
genes into the environment due to maternal inheritance of chloroplast genomes, multiple copies 214 
of chloroplast genome per cell enables high levels of protein expression and possibility of 215 
coexpression of multiple genes provides a way to produce vaccines requiring multiple epitopes 216 
for activity, homologus recombination for transfer of transgene into chloroplast genome [61-65]. 217 
Chloroplast transformation also enables post-translational changes in expressed proteins and 218 
correct folding required for antigenicity [66]. Further, foreign protein in the chloroplast does not 219 
interfere with growth and morphology of the host plant [64]. Investigators have reported 220 
expression of many antigenic epitopes in this regard including hepatitis, cervical cancer, AIDS,  221 
and small pox. Other examples include; HPV-16 L1 VLPs epitope in tobacoo [67], Potato virus 222 
X (PVX) coat protein (CP) fused with HPV-16 E7 oncoprotein (E7-CP) in tobacoo [68], 223 
Hepatitis E virus (HEV E2) in tobacco [69], Rotavirus (VP6) in tobacco [70], HIV (p24-Nef) in 224 
tobacco, tomato [71], CTB fused with fibronectin-binding domain (D2) of S. aureus (CTB-D2) 225 
in Chlamydomonas [72], and Cholera toxin B–proinsulin fusion protein (CTB-Pins) in tobacco 226 
and lettuce [73]. Though transplastomic expression of vaccine antigens is considered relatively 227 
safe compared to nuclear expression, these are also associated with politropic effects [74] such as 228 
male sterility [75] and stunted growth of the host plant. Still, many other regulatory issues should 229 
be challenged such as, degradation of proteins, efficacy of vaccines produced in chloroplast etc. 230 
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In most of the cases, transplastomic study has been conducted in tobacco plants and other species 231 
need to be explored [76].  232 
3.2 Genome editing 233 
Though genome editing techniques are associated with manipulating DNA at a specific location 234 
or repair of existing DNA. For this purpose commonly explored technologies are zinc-finger 235 
nucleases (ZFNs), CRISPR-associated protein 9, and transcription activator-like effector 236 
nucleases (TALENs) [77, 78]. Recent development in genome editing techniques have enabled 237 
researchers to manipulate the genome at the sequence specific level for variety of purposes [78-238 
80]. Genome editing has been used to engineer cell lines and organisms through gene knockout, 239 
deletion, correction, inversion [81-83] and chromosomal translocation [84]. Moreover, these 240 
sequence specific nucleases have been effectively used for plant genetic engineering [85]; wheat 241 
[86], soybean [87], barley, Brassica oleracea [88], tomato genome [89] and Arabidopsis [90]. 242 
Though genome editing may be caused by mutagenesis during cell culture but such reports in the 243 
generation of transgenic plants for edible vaccines are limited. One example is the  production of 244 
an edible vaccine against cedar pollen allergy in rice [91] where researchres have suggested cell 245 
culture steps as cause of mutation on the basis of whole genome sequencing between transgenic 246 
line and host.  247 
 248 
3.3 Epitope prediction for vaccine development using computational tools 249 
Antibody epitope prediction is crucial step of vaccine design. Various considerations such as 250 
hydrophilicity, flexibility, accessibility, turns, exposed surface, polarity and antigenic propensity 251 
of polypeptides chains have to be correlated with the location of continuous epitopes. Thus 252 
epitope prediction is important when designing vaccines. System level understanding of cells 253 
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with the help of in silico methods can also help the prediction and localization of epitopes [15]. 254 
Still, these techniques are not used for design of antigen for plantibodies but these methods are 255 
quick, accurate and can be helpful in plantibody manufacturing and may be vital in the 256 
biopharmaceutical industries (Table 4).  257 
 258 
Insert Table 4 259 
Moreover, Figure 4 also depicts the various bioinformatics based methods which can be used for 260 
epitope prediction. Some important methods are like; Artificial Neural Network [92-94], Hidden 261 
Markov Models (HMMs) and Molecular dynamics simulations (MD) [95]. Structure activity 262 
relationships (SARs), support vector machines (SVMs) and virtual screening (VS).  263 
 264 
4. Common problems associated with plantibodies 265 
There are certain important issues which needs to be discuseed towards effectual plantibodies 266 
development. Some of them are explained in this section. 267 
4.1 Immuno-modulation 268 
Immune-modulation has been used to study antigen/epitope function as well as antigen 269 
mistargeting [96]. There are certain ways in which antibody affects protein: competitive and 270 
allosteric inhibition and interference in the protein folding. Antigen mistargeting in tobacco 271 
plants resulted in scFv fragment accumulation in the ER and binding of abscisic acid (ABA). 272 
TMV infection in tobacco plants resulted in the expression of a TMV virion binding scFv 273 
fragment [97,98]. Lessening of necrotic local lesion numbers was observed during virus infection 274 
as well as increased scFv targeting to the apoplast. In another study, camelid nanobodies have 275 
been recognized as an effective countermeasure against Broad Bean Mottle Virus (BBMV) 276 
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infection. It was observed that these nanobodies controlled growth of BBMV virus in Vicia faba 277 
[99]. 278 
 279 
4.2 Development and commercialization issues  280 
Although plants are being exploited successfully for expression of antigenic epitopes  in  the 281 
production of edible vaccines, there are still many challenges limiting their success. Despite the 282 
fact many vaccines have completed phase III of clinical trials [2], to date, no vaccine is available 283 
for market consumption [17]. Problems include: Improper gene transfer techniques, low levels of 284 
expression, difficulty in promoter identification, variation, codon  biasing and scantly regulatory 285 
sites, inappropriate polyadenylation and unsuitable nuclear transport, mRNA instability and 286 
positional effects, epigenetic silencing, insufficient immune response after administration, 287 
regulatory issues and maintenance of GMP standard [100-102], selection of antigen and host 288 
[103] and consistency of dose [104]. 289 
 290 
5. Conclusions and future prospects 291 
The present review has demonstrated several examples on the production of recombinant 292 
proteins in plants, specifically vaccine production. Nevertheless, commercialization of PDAs 293 
faces several limitations. Biosafety and environmental issues are affecting the promotion of bulk 294 
cultivation of engineered plants, however existing regulatory norms are to be followed as per 295 
guidelines as per stakeholder’s country. Researchers need to increase levels of antigen 296 
expression in plants along with targeted expression but it needs more focused approach.  297 
Nevertheless, there is a requirement for further comprehensive studies of specific antigens 298 
previous to plant-based vaccines can be used as a product. Presently, USDA and FDA regulate 299 
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production of plant derived vaccines. Although these regulatory bodies are controlling the 300 
production of these vaccines, we need to deliberate upon the current insights on the evaluation of 301 
such products towards commercialization. 302 
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Key Points 687 
1. Plant expression systems have several intrinsic advantages in terms of speed, costs, 688 
scalability and safety. 689 
2. Plant based antigen expression has emerged as a viable technology for the production of 690 
recombinant proteins. 691 
3. To date, numerous antibodies are reported in a variety of different plant species 692 
4. The success of plant derived antibodies mainly depends on the development of transient 693 
and stable transformation for commonly grown crops, and ease of cultivation. 694 
695 
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Figure legends: 696 
 697 
Figure 1. Demonstration of approaches used for the production of plantibodies. In silico tools 698 
assist in epitope prediction for antibodies to be expressed as plant derived antibodies (PDAbs). 699 
The gene designed for vaccination is integrated into a vector and transferred into plant cells via 700 
suitable gene transfer approaches. 701 
 702 
Figure 2. Recombination and selective breeding approaches used for the production of PDAbs 703 
 704 
Figure 3. Schematic overview of 2A function. (A) The foot-and-mouth disease virus polyprotein 705 
includes the L proteinase  (Lpro), the capsid proteins domain, 2A and two further domains 706 
comprising the replicative proteins.  The 18aa long 2A sequence is shown together with the site 707 
of cleavage (arrow) and the N-terminal proline of 2B, instantly downstream of 2A. (B) Gene 708 
sequences 1 (with no stop codon) and 2 are concatenated into a single (trans) gene via a 2A 709 
linker. The translation products are synthesised in an equimolar ratio, while, protein 1 upstream 710 
of 2A bears a C-terminal extension of 2A, and protein 2 bears an N-terminal proline residue 711 
 712 
Figure 4. Flow-chart representing algorithms for the implementation of epitope-based vaccine 713 
design. 714 
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1. Plant expression systems have several intrinsic advantages in terms of speed, costs, 
scalability and safety. 
2. Plant based antigen expression has emerged as a viable technology for the production 
of recombinant proteins. 
3. To date, numerous antibodies are reported in a variety of different plant species 
4. The success of plant derived antibodies mainly depends on the development of 
transient and stable transformation for commonly grown crops, and ease of 
cultivation. 
 
 
Page 33 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
Dr. Kashyap Kumar Dubey 
Dr. Kashyap Kumar Dubey is presently working as Associate Professor and Head of 
Department of Biotechnology at Central University of Haryana, India. His research interests 
are in the field of bioprocess engineering and plant based metabolites. 
Dr.  Garry A Luke  
Dr. Garry A. Luke is Research Fellow at School of Biology at University of St Andrews, UK. 
He research interests are in the field of virology and molecular biology. 
 Dr. Caroline Knox  
Dr. Caroline Knox is Associate Professor at Department of Biochemistry, Microbiology and 
Biotechnology, Rhodes University South Africa. Her research interests are in the field of 
virology. 
Dr. Punit Kumar: 
Dr. Punit Kumar is Ph.D. in Biotechnology from M.D. University, Rohtak, India. His 
research interests are in the field of microbiology and plant based metabolites. 
Prof. Brett I. Pletschke  
Dr. Brett Pletschke is Professor at Department of Biochemistry, Microbiology and 
Biotechnology, Rhodes University South Africa. His research interests are in the field of 
Enzymes, Enzyme Inhibitors and the Bio economy. 
Puneet Kumar Singh 
Dr. Puneet Kumar Singh is PhD from Microbiology from M.D. University, Rohtak, India. 
His research interests are in the field of Bioinformatics and systems biology. 
Dr. Pratyoosh Shukla 
Dr. Pratyoosh Shukla is Professor and Head at Department of Microbiology at M.D. 
University, Rohtak, India. His research interests are in the field of enzyme technology and 
protein bioinformatics. 
 
Page 34 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
1 
 
Table 1. Transgenic/ transient expression of different antigenic epitopes as vaccine candidates in 1 
various plant systems 2 
 3 
Plant 
expression 
system 
Method of 
transgenesis  
Pathogen Antigenic 
epitope 
Reference 
Nicotiana 
benthamiana 
Agrobacterium 
mediated 
transformation 
Infleunza Hemagglutinin 
(HA) 
[105]  
Potato Agrobacterium 
mediated 
transformation 
Hepatitis B virus hepatitis B 
surface antigen 
(HBsAg) 
surface S and 
preS2 antigen 
[106]  
Tomato Agrobacterium 
mediated 
transformation 
Hepatitis B virus hepatitis B 
surface antigen 
(HBsAg) 
[107]  
Tobacco and 
maize 
Agrobacterium 
mediated 
transformation 
Rabies Monoclonal 
antibody (MAb) 
E559  
[108]  
Barley Agrobacterium 
tumefaciens  
mediated 
HIV Anti-HIV-1 
monoclonal 
antibody 2G12  
[109]  
Carrot Agrobacterium 
mediated 
transformation  
E. coli LT-B [110]  
Maize Particle 
bombardment 
Vibrio cholera 
E. coli 
Cholera toxin 
beta subunit  
(CTB) and LT-
B 
[21]  
Maize 
endosperm 
Particle 
bombardment 
HIV Anti HIV 2G12 [111]  
Tobacco Agrobacterium-
mediated 
transformation 
Vibrio cholera cholera toxin 
subunit B 
(CTB) 
[112]  
Potato Agrobacterium-
mediated 
transformation 
Rota virus Rota Virus VP7 [113]  
Arabidopsis 
thaliana 
Agrobacterium-
mediated 
transformation 
Mycobacterium 
tuberculosis  
Tuberculosis 
antigen 
[114]  
Nicotiana 
benthamiana 
Agroinfiltration Ebola virus Ebola 
glycoprotein 
(GP1) 
[115]  
Tomato Agrobacterium- Foot-and-mouth P1-2A, and [116] 
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mediated 
transformation 
disease virus protease, 3C 
Tobacco Biolistic method Foot-and-mouth 
disease virus 
VP1 [117] 
Nicotiana 
benthamiana 
Agrobacterium-
mediated 
transformation 
Plasmodium 
falciparum 
Pfs25-CP VLP [118] 
 4 
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Table 2. Immunological responses of vaccines against animals/human pathogens produced 1 
through genomic transformation of plants with different antigenic gene epitopes 2 
 3 
 4 
Pathogen Antigen Plant 
Expression 
System 
Test system: 
Immune response 
Reference 
Enterotoxigenic 
E.coli 
Enterotoxin  
B subunit 
(LT-B) 
Tobacco leaf Mouse:Serum and 
mucosal antibodies 
to LT-B 
[119]  
[120]  
Enterotoxigenic E. 
coli 
Enterotoxin 
B subunit 
(LT-B) 
Potato tuber Mouse:Serum and 
mucosal antibodies 
to LT-B; protected 
against challenge 
with toxin 
[121]  
[122]  
Norwalk virus Capsidprotein Nicotiana 
benthamiana 
 [123]  
Vibrio cholerae Cholaratoxin 
B subunit 
(CT-B) 
Potato tuber and 
leaf callus 
Mouse:Serum 
antibodies to CT-B 
with tuber or 
callus; decreased 
severity 
[59]  
[124]  
 
Hepatitis B virus Suface 
antigen 
(HbsAg) 
Lupin callus 
and Lettuce leaf 
Mouse:Serum 
antibodies to 
(HbsAg) 
Human:Serum 
antibodies to 
HbsAg 
[125]  
[126]  
Tuberculosis Tuberculosis 
antigen 
Arabidopsis 
thaliana 
 [114]  
 5 
 6 
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Table 3. Immunological response of transiently expressed vaccines against animals/human 1 
pathogens in different plant systems 2 
 3 
Pathogen Antigenic 
epitope 
Plant Source 
of viral 
coat 
protein 
Test system: 
Immune 
response 
Reference 
Human 
rhinovirus 
VP1 Cowpea 
leaf 
CPMV Rabbit:serum 
antibodies to 
VP1 
[127] 
Human 
immune 
Deficiency 
Virus (HIV-1) 
Gp41 
 
Cowpea 
leaf 
CPMV Mouse:serum 
antibodies to 
gp41 
 
[128]  
Rabies virus Drg 24 
 
Tobacco 
leaf and 
spinach 
leaf 
AMV Mouse:serum 
antibodies and 
mucosal 
antibodies to 
Drg24 
[129]  
Mink entritis 
virus  
Capsid proteins 
VP2 
Black 
eyed 
bean leaf 
CPMV Mouse:serum 
antibodies to 
VP2 
[130]  
Staphylococcus 
aureus 
D2 Peptide of 
FnBP Binding 
protein  
Cowpea 
leaf 
CPMV Mouse:serum 
antibodies to D2 
[131]  
Measles virus Hemagglutinin 
(H) glycoprotein 
Carrot AMV Mouse:serum 
antibodies to H 
[110]  
 4 
 5 
 6 
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Table 4. An overview of various In Silico methods of Epitope prediction in Plantibodies 
engineering 
 
Database  
and its 
URL 
Brief description Functions Remarks Reference 
IMGT  
(Internation
al 
ImMunoGe
neTics 
information 
system) 
http://www.
imgt.org/ 
It is immunogenetics 
and immunoinfor-
matics resource  
provides a common access 
to sequence, genome and 
structure Immunogenetics 
data, based on the concepts 
of IMGT-ONTOLOGY 
Created by Marie-
PauleLefranc 
(Université de 
Montpellier and 
CNRS)., Year: 1989 
[132]  
SYFPEITH
I (A 
Database 
for MHC 
Ligands 
and Peptide 
Motifs) 
http://www.
syfpeithi.de
/ 
This comprises more 
than 7000 peptide 
sequences known to 
bind class I and 
class II MHC 
molecules. 
The prediction is based on 
published motifs (pool 
sequencing, natural 
ligands) and takes into 
consideration the amino 
acids in the anchor and 
auxiliary anchor positions, 
as well as other frequent 
amino acids. 
 [133]  
IEDB 
(Immune 
Epitope 
Database 
and 
Analysis 
Resource) 
http://www.
immuneepit
ope.org/ 
It is a resource 
center for data 
related to antibody 
and T cell epitopes 
for humans, non-
human primates, 
rodents, and other 
animal species. 
 
It predicts antibody and T 
cell epitopes has epitope 
analysis tools as well as 
peptide processing 
predictions 
 
As on April 26, 2015 it 
has 
Peptidic Epitopes-
130671,  
Non-Peptidic Epitopes-
2199 
T Cell Assays-271157 
B Cell Assays -
180401 
MHC Ligand Assays-
 323330 
Epitope Source 
Organisms-3383 
Restricting MHC 
Alleles-683 
References-16860 
[134]  
AntiJen 
http://www.
jenner.ac.u
It contains entries of 
binding data on 
MHC ligands, 
It accepts epitope strings 
with variable amino acid 
positions and alternate 
contains over 24,000 
entries of binding data 
on MHC ligands, 
[135]  
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

k/antijen/ TR-peptide-MHC 
complexes, T cell 
epitopes, TAP, B 
cell epitopes and 
immunological 
protein–protein 
interactions.  
amino acid in any epitope 
string, 
an optional filter can be 
used to target experimental 
data of interest, 
delimiting it also searches 
on the basis of epitope 
length 
Peptide library, copy 
numbers and diffusion 
coefficient data are 
also included 
 
MHCBN  
(Major 
Histocompa
tibility 
Complex 
(MHC) 
Binding, 
Non-
binding 
peptides 
and T-cell 
epitopes) 
http://www.
imtech.res.i
n/raghava/
mhcbn/ 
It contains data of  
MHC binders and 
non-binders, TAP 
binders and non-
binders, and T-cell 
epitopes 
 
The database provides 
information about allele 
specific MHC binding 
peptides, MHC non-
binding, TAP binding, TAP 
non-binding peptides and 
T-cell epitopes reported in 
literature 
25860 MHC binders 
and  
non-binders, 1053 TAP 
binders and non-
binders, and 6722 T 
cell epitopes 
 
[136]  
     
IPD 
(Immuno 
Polymorphi
sm 
Database)ht
tp://www.e
bi.ac.uk/ipd
/ 
IPD is a set of 
specialist databases 
related to the study 
of polymorphic 
genes in the immune 
system. The IPD-
MHC Database 
provides a 
centralised 
repository for 
sequences of the 
Major 
Histocompatibility 
Complex (MHC) 
from a number of 
different species. 
It consists of four 
databases: IPD-KIR for 
sequences of killer-cell IG-
like receptors; IPD-MHC 
for MHC sequences of 
different species; IPD-HPA 
for alloantigens expressed 
only on platelets and IPD-
ESTAB for access to the 
European Searchable 
Tumour Cell-Line 
Database, a cell bank of 
immunologically 
characterized melanoma 
cell lines 
Through a number of 
international 
collaborations IPD is 
able to provide the 
MHC sequences of 
different species 
[137]  
Epitome 
http://www.
cubic.bioc.c
olumbia.ed
Epitome stores 
information of 142 
antigens 
fromprotein–
It includes the detailed 
description of  
residues involved in the 
interaction and their 
Along with that 
interactions can be 
visualized using an 
interface into Jmol. 
[138]  
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u/services/
Epitome/ 
antibody complex 
structures 
sequence / 
structure environments. 
Allergen 
Nomenclat
ure 
Database 
http://www.
allergen.org
/ 
This website is the 
official site for the 
systematic allergen 
nomenclature that is 
approved by the 
World Health 
Organization and 
International Union 
of Immunological 
Societies 
(WHO/IUIS) 
Allergen 
Nomenclature Sub-
committee. 
The Allergen Nomenclature 
Database contains 
information of allergens 
and isoallergens developed 
and maintained by the 
Allergen Nomenclature 
sub-committee of the IUIS. 
 
Data submissions are 
accepted and annotated 
by the committee 
members 
 
[139]  
BIFS 
(Bioinform
atics for 
Food 
Safety) 
http://www.
iit.edu/~sge
ndel/fa.htm 
BIFS 
(Bioinformatics for 
Food Safety) is 
maintained by 
Illinois Institute of 
Technology 
 BIFS contains 
information on 453 
food allergens 
(64 animals, 389 
plants), 645 non-food 
allergens, 
and 75 wheat gluten 
proteins 
[140]  
SDAP 
(Structural 
Database of 
Allergenic 
Proteins) 
http://www.
fermi.utmb.
edu/SDAP/ 
SDAP is a Web 
server that integrates 
a database of 
allergenic proteins 
with various 
computational tools 
that can assist 
structural biology 
studies related to 
allergens 
SDAP stores information of 
887 allergenic proteins. 
It contains various tools for 
FAO/WHO 
allergenicitytests and 
assessing the IgE-binding 
potential ofgenetically 
modiﬁed food proteins 
SDAP contains 
information about the 
allergen name, source, 
sequence, structure, 
IgE epitopes and 
literature references. 
[141]  
FARRP 
(Food 
Allergy 
Research 
and 
Resource 
Program) 
http://www.
farrp.org/ 
FARRP was 
established in 1995 
as a cooperative 
venture between the 
University of 
Nebraska and seven 
founding industry 
charter members.   
FARRP contains 1251 
sequences of known and 
putative allergens derived 
from scientiﬁc literature 
and public databases 
 
FARRP works with 
research institutions, 
governmental 
authorities, consumer 
groups, and scientific 
societies around the 
globe to improve the 
safety of food products 
for consumers with 
food allergies and 
sensitivities. 
[142] 
Page 41 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review


Allergome 
http://www.
allergome.o
rg/ 
The Allergome web 
site has been 
designed to supply 
information on 
Allergenic 
Molecules 
(Allergens). 
Allergome emphasizes the 
annotation of allergens 
that cause IgE-mediated 
disease.  
The database contains 
information derived 
from 5800 selected 
scientiﬁc literatures. 
[143]  
ALPSbase 
(Autoimmu
ne 
Lymphopro
liferative 
Syndrome 
Database)  
Autoimmune 
lymphoproliferative 
syndrome database 
It supports basic and 
applied research to better 
understand, treat, and 
ultimately prevent 
infectious, immunologic, 
and allergic diseases 
The database 
emphasize on 
extensive research 
portfolio of basic and 
applied research to 
prevent, diagnose, and 
treat infectious 
diseases such as 
HIV/AIDS and other 
sexually transmitted 
diseases, influenza, 
tuberculosis, malaria, 
and illness from 
potential agents of 
bioterrorism. 
[144] 
AntigenDB 
http://www.
imtech.res.i
n/raghava/a
ntigendb 
 
The data on antigens 
were extracted from 
the primary 
literature. Antigens 
provided are from 
immunological 
databases (IEDB, 
MHCBN, AntiJen, 
BCIPEP) and other 
databases (e.g. 
Swiss-Prot) 
An immunoinformatics 
database of pathogen 
antigens 
 
Provides Sequence, 
structure, and other 
data on pathogen 
antigens. 
[145]  
BCIpep 
http://bioinf
ormatics.ua
ms.edu/mirr
or/bcipep/ 
The Bcipep is a 
collection of 
immunogenic 
peptides.The 
database consists of 
nearly 555 
antigenic peptide 
with varying 
immunogenic 
activity. 
Bcipep is a database of 
experimentally determined 
linear B-cell epitopes of 
varying immunogenicity 
collected from literature 
and other publicly available 
databases 
The database now 
contains 2700 entries 
including 1350 
epitopes in the non-
redundant datasets. 
[146]  
pVAC-Seq 
https://githu
personalized Variant 
Antigens by Cancer 
A flexible, streamlined 
computational workflow 
help to evaluate tumor- 
specific neoepitopes in 
[147]  
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b.com/griffi
thlab/pVA
C-Seq 
Sequencing (pVAC-
Seq) 
for identification of 
personalized Variant 
Antigens by Cancer 
Sequencing (pVAC-Seq) 
that integrates tumor 
mutation and expression 
data (DNA- and RNA-Seq) 
a much-reduced time, 
thereby increasing its 
applicability for 
clinical use 
NetCTL Prediction HLA-I 
restricted cytotoxic 
T cell epitopes 
 
One hundred and thirty one 
peptides have affinities for 
the HLA-I supertypes and 
only 21 were found to 
induce T cell responses 
 [148]  
SYFPEITH
I 
Prediction of HLA 
binding peptides 
Two novel HLA-A 
⁄0201 restricted epitopes 
 [149]  
 


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Figure 1: Demonstration of approaches used for the production of plantibodies. In silico tools assist in 
epitope prediction for antibodies to be expressed as plant derived antibodies (PDAbs). The gene designed for 
vaccination is integrated into a vector and transferred into plant cells via suitable gene transfer approaches. 
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Figure 2. Recombination and selective breeding approaches used for the production of PDAbs  
 
79x53mm (300 x 300 DPI)  
 
 
Page 45 of 47
http://mc.manuscriptcentral.com/bfgp
Manuscripts submitted to Briefings in Functional Genomics
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Figure 3. Schematic overview of 2A function. (A) The foot-and-mouth disease virus polyprotein includes the 
L proteinase  (Lpro), the capsid proteins domain, 2A and two further domains comprising the replicative 
proteins.  The 18aa long 2A sequence is shown together with the site of cleavage (arrow) and the N-
terminal proline of 2B, instantly downstream of 2A. (B) Gene sequences 1 (with no stop codon) and 2 are 
concatenated into a single (trans) gene via a 2A linker. The translation products are synthesised in an 
equimolar ratio, while, protein 1 upstream of 2A bears a C-terminal extension of 2A, and protein 2 bears an 
N-terminal proline residue  
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Figure 4. Flow-chart representing algorithms for the implementation of epitope-based vaccine design.  
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